Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK‐1 activation in the NF‐κB and MAPK pathwaysEun‐Ha Joh, Dong‐Hyun Kim|British Journal of Pharmacology|2010Cited by 57